A funding drought, plummeting valuations, and the recent shutdown of Ketamine Wellness Centers — one of the largest chains of ketamine clinics — signal that investors may have soured on the space.

In this brief, we use CB Insights data to assess the current state of the psychedelics market. We look at the following data points:

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Is the psychedelics space experiencing a comedown? appeared first on CB Insights Research.

But the post-Covid comedown has been hard on connected fitness equipment players — which gained a lot of attention during the height of the pandemic from locked-down consumers — leading to disappointing hardware sales for MIRROR, as mentioned on Lululemon’s most recent earnings call:

“The overall at-home fitness space remains challenged. MIRROR hardware sales during the holiday season came in below our expectations” 

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Lululemon may be able to recoup its MIRROR investment despite challenges in the connected fitness equipment space appeared first on CB Insights Research.

Its 3 core businesses — The Cigna Group, Cigna Healthcare, and Evernorth — cater to both payer and provider markets and provide coverage to 18M medical customers.

Cigna is betting big on technology to provide patients with more precise and personalized care experiences. It is looking at ways to use technology to conveniently deliver care, strengthen its insurance offerings, and do more with patient health data.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Analyzing Cigna’s growth strategy: How the healthcare payer is expanding into virtual care, home health, and insurtech appeared first on CB Insights Research.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Analyzing a16z’s AI investment strategy: How the VC is funding the AI global takeover appeared first on CB Insights Research.

This achievement is partly attributed to its pioneering work in accelerated computing, which uses specialty hardware to complete demanding software tasks much faster than previously possible.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Analyzing NVIDIA’s growth strategy: How the semiconductor leader is powering generative AI and the future of computing appeared first on CB Insights Research.

Knowledge discovery products use machine learning and semantic search algorithms to surface relevant scientific and experimental data. Companies in this space offer solutions that take a variety of public or private data sources as input.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Knowledge discovery for pharma and CRO leaders appeared first on CB Insights Research.

Cloud research and development (R&D) allows for digitizing drug discovery and preclinical and other R&D laboratory workflows and processes. Typical features include electronic lab notebooks and lab information management systems.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Cloud R&D software for pharma and CRO leaders appeared first on CB Insights Research.

Nature mining uses biological data from natural sources — such as fungi, microbes, and plants — to discover novel drug candidates. Platforms typically collect data through genome sequencing and/or manually cataloging molecules produced by the organism. Then, they apply machine learning (ML) to parse the data and uncover drug candidates.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Nature mining for pharma and CRO leaders appeared first on CB Insights Research.

One of the earliest applications of AI in healthcare was in diagnostic imaging, where big tech companies and startups alike developed computer vision algorithms to detect anomalies from MRIs, CT scans, X-rays, and ultrasounds. 

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post 96 AI companies building the next generation of radiology tech appeared first on CB Insights Research.

Its portfolio includes several high-valued tech companies, such as Mindbody, Pluralsight, and Ping Identity.

Since the beginning of 2022, Vista Equity Partners has been involved in numerous transactions and has participated in multiple mega-rounds (deals worth $100M+). The firm has also taken several companies private at billion-dollar valuations.

Using CB Insights data, we mapped how Vista Equity Partners has spread its investments and acquisitions since 2022 across categories like cybersecurity, financial services, enterprise tech, and more.

CB Insights clients can dig deeper into all 21 deals listed above using this CB Insights platform search.

The post Analyzing Vista Equity Partner’s investment strategy: Where the PE firm is betting big across key industries appeared first on CB Insights Research.

AVP has $1.2B of assets under management and invests in data-driven startups that can impact healthcare, customer experience, and underwriting performance. These areas represent opportunities that are relevant to the entire insurance industry.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Analyzing AXA Venture Partners’ investment strategy: What the CVC’s investments reveal about the future of insurance appeared first on CB Insights Research.

It channeled its efforts into 5 main areas within the sector, as detailed in its Q4’22 financial highlights issued in January 2023. These include:

• Tools & diagnostics
• Medical devices
• Biopharma
• Healthcare services
• Digital health & health tech

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Silicon Valley Bank’s healthcare investment syndicate map. Which VCs did it work with most often on healthcare deals? appeared first on CB Insights Research.

Technology is becoming a bigger part of UHG’s value proposition and growth strategy. Its tech-forward health services subsidiary Optum accounts for over 56% of UHG’s total revenue.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Analyzing UnitedHealth Group’s growth strategy: How the healthcare titan is betting on tech to expand its care offerings appeared first on CB Insights Research.

The company’s portfolio includes some of the most iconic and successful companies in the world, like SolarWinds, Blue Coat, Stamps.com, and SailPoint.

Thoma Bravo has participated in 27 transactions since 2022. The firm also invested in 5 mega-round ($100M+) deals and took multiple companies private at billion-dollar valuations during that time frame.

Using CB Insights data, we mapped how Thoma Bravo spread its investments and acquisitions since 2022 across categories like cybersecurity, financial services, enterprise software, and more.

CB Insights clients can dig deeper into all 27 deals listed above using this CB Insights platform search.

The post Analyzing Thoma Bravo’s investment strategy: Where the PE firm is betting big across key industries appeared first on CB Insights Research.

Thanks to the 21st Century Cures Act, which added specific requirements for data sharing and costly penalties for non-compliance and data blocking, these healthcare data silos are finally collapsing. 

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post 87 companies revolutionizing healthcare data interoperability appeared first on CB Insights Research.

This presents a massive opportunity for big tech companies. Drug discovery technology is a $120B market, and corporate executives are beginning to notice.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post What is Microsoft doing in drug discovery and clinical research? appeared first on CB Insights Research.

Telehealth platforms are also known as virtual care platforms. The players in this market utilize virtual technologies to provide members with care options to be seen on demand and regardless of location. The introduction of new technologies, such as digital medical kits supporting virtual visits and the use of artificial intelligence/machine learning (AI/ML) to provide clinicians with relevant clinical information in preparation for visits, allows for more efficient visits to be conducted.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Telehealth platforms for healthcare payers appeared first on CB Insights Research.

Major healthcare systems and providers are already tapping into this opportunity by investing in healthcare technologies geared towards the elderly population.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Prioritizing 13 technologies transforming senior care for healthcare providers appeared first on CB Insights Research.

Historically done via phone calls and mailed letters, the care coordination market now offers a more online, personalized management plan to optimize ongoing care. These solutions reduce the risks of undiagnosed health issues and hospitalization.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Care coordination and management for healthcare payers appeared first on CB Insights Research.

Home health enablement supports members through in-home care options for diagnostic testing, ongoing treatment, and acute care needs. As a result of the Covid-19 pandemic, more care — ranging from basic medical exams to hospital-level care — has been transitioned to the home setting. Payers have benefited from higher compliance to care as well as reduced costs based on the efficiencies of at-home services.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Home health enablement for healthcare payers appeared first on CB Insights Research.

Digital therapeutics (DTx) combines evidence-based research with digital technologies to provide members with on-demand, personalized treatment options for ongoing medical ailments. Payers are investing in this technology in an increasingly competitive market to attract more members and reduce overall care costs.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Digital therapeutics for healthcare payers appeared first on CB Insights Research.

Wirelessly connected devices use electromagnetic waves to transfer data between 2 or more points without a physical connection. These include handheld exam tools, wearable ambulatory monitors, and large, stationary medical equipment.

Clinical applications are becoming more linked, proactive, and personalized due to these devices’ data volume and frictionless transfer. Wireless devices increase providers’ workflows, asset use, staffing, and Capex spending.

Want the full expert post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post Market Trend Report: Wireless connectivity for medical device leaders appeared first on CB Insights Research.